Scholars Central

ArticlePublished 28 Jun 2024

Artesunate Ameliorates Osteoarthritis Pain and Inflammatory Response of Chondrocytes in rats Through Modulation of Toll-Like Receptor 4/Myeloid Differentiation Response Gene 88/Nuclear Factor Kappa B Pathway

Authors: Yisong Sun, Dong Fang, Lei Qi

Indian Journal of Pharmaceutical Sciences

Volume 86 · Issue 3 · Pages 1083–1090

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This study examined the effects of artesunate on pain and inflammatory response of chondrocytes in osteoarthritis in rats and its effect on toll-like receptor 4/myeloid differentiation response gene 88/nuclear factor kappa B pathway. Thirty specific-pathogen free-grade Sprague-Dawley rats were collected and divided into 3 groups. The knee osteoarthritis model was established by intra-articular injection of papain in both osteoarthritis and artesunate groups. After 6 w of modeling in each group, the artesunate group was treated with 60 mg/kg of artesunate intraperitoneal injection, while the Sham and osteoarthritis groups were injected with an equal amount of saline for 4 w consecutively, once in a day. After 10 w of modeling, foot printing experiments were performed to analyze the behavior of murine pain hypersensitivity reaction in each group, and enzyme-linked immunosorbent assay was performed to determine the interleukin-1 beta, interleukin-6, interleukin-10 and tumor necrosis factor-alpha. The degree of articular cartilage destruction was observed under the microscope of hematoxylin and eosin staining. Reverse transcription polymerase chain reaction was used to detect toll-like receptor 4/myeloid differentiation response gene 88/nuclear factor kappa B messenger ribonucleic acid while Western blotting was used to detect the proteins related to toll-like receptor 4/myeloid differentiation response gene 88/nuclear factor kappa B signaling pathway. In rats with osteoarthritis, artesunate can reduce pain and chondrocyte inflammatory response which may be attributed to the control of the toll-like receptor 4/myeloid differentiation response gene 88/nuclear factor kappa B pathway.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Yisong Sun”
  • BylineArticles whose byline prints “Dong Fang”
  • BylineArticles whose byline prints “Lei Qi”